These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 21307130)
1. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cheng Y; Ren X; Zhang Y; Patel R; Sharma A; Wu H; Robertson GP; Yan L; Rubin E; Yang JM Cancer Res; 2011 Apr; 71(7):2654-63. PubMed ID: 21307130 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma. Zhao YY; Tian Y; Liu L; Zhan JH; Hou X; Chen X; Zhou T; Huang Y; Zhang L Drug Des Devel Ther; 2018; 12():2655-2663. PubMed ID: 30214154 [TBL] [Abstract][Full Text] [Related]
3. Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Wu H; Zhu H; Liu DX; Niu TK; Ren X; Patel R; Hait WN; Yang JM Cancer Res; 2009 Mar; 69(6):2453-60. PubMed ID: 19244119 [TBL] [Abstract][Full Text] [Related]
4. eEF-2 kinase, another meddler in the "yin and yang" of Akt-mediated cell fate? Cheng Y; Yan L; Ren X; Yang JM Autophagy; 2011 Jun; 7(6):660-1. PubMed ID: 21460616 [TBL] [Abstract][Full Text] [Related]
5. MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Cheng Y; Zhang Y; Zhang L; Ren X; Huber-Keener KJ; Liu X; Zhou L; Liao J; Keihack H; Yan L; Rubin E; Yang JM Mol Cancer Ther; 2012 Jan; 11(1):154-64. PubMed ID: 22057914 [TBL] [Abstract][Full Text] [Related]
6. Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro. Guan YD; Jiang SL; Yu P; Wen M; Zhang Y; Xiao SS; Xu XJ; Cheng Y Acta Pharmacol Sin; 2018 Apr; 39(4):642-648. PubMed ID: 29239350 [TBL] [Abstract][Full Text] [Related]
7. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro. Yu P; Wang HY; Tian M; Li AX; Chen XS; Wang XL; Zhang Y; Cheng Y Acta Pharmacol Sin; 2019 Sep; 40(9):1237-1244. PubMed ID: 30914761 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Zhang L; Wang H; Xu J; Zhu J; Ding K Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536 [TBL] [Abstract][Full Text] [Related]
9. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy. Guan Y; Jiang S; Ye W; Ren X; Wang X; Zhang Y; Yin M; Wang K; Tao Y; Yang J; Cao D; Cheng Y Cell Death Dis; 2020 Nov; 11(11):948. PubMed ID: 33144562 [TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
11. Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Wu H; Yang JM; Jin S; Zhang H; Hait WN Cancer Res; 2006 Mar; 66(6):3015-23. PubMed ID: 16540650 [TBL] [Abstract][Full Text] [Related]
12. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. Degtyarev M; De Mazière A; Orr C; Lin J; Lee BB; Tien JY; Prior WW; van Dijk S; Wu H; Gray DC; Davis DP; Stern HM; Murray LJ; Hoeflich KP; Klumperman J; Friedman LS; Lin K J Cell Biol; 2008 Oct; 183(1):101-16. PubMed ID: 18838554 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells. Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918 [TBL] [Abstract][Full Text] [Related]
14. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Kuo PL; Hsu YL; Cho CY Mol Cancer Ther; 2006 Dec; 5(12):3209-21. PubMed ID: 17172425 [TBL] [Abstract][Full Text] [Related]
15. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227 [TBL] [Abstract][Full Text] [Related]
16. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin. Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960 [TBL] [Abstract][Full Text] [Related]
18. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Rebecca VW; Massaro RR; Fedorenko IV; Sondak VK; Anderson AR; Kim E; Amaravadi RK; Maria-Engler SS; Messina JL; Gibney GT; Kudchadkar RR; Smalley KS Pigment Cell Melanoma Res; 2014 May; 27(3):465-78. PubMed ID: 24490764 [TBL] [Abstract][Full Text] [Related]
20. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]